Literature DB >> 12466230

Beta 2 adrenergic receptor 5' haplotypes influence promoter activity.

Sharon E Johnatty1, Maha Abdellatif, Lawrence Shimmin, Richard B Clark, Eric Boerwinkle.   

Abstract

1. Transcriptional control of the human beta(2) adrenergic receptor gene (ADRB2) predominantly resides within a 549 base pair region immediately 5' to the start of translation. Within this region, four naturally occurring polymorphisms, -468 C-->G, -367 T-->C, -47 T-->C, and -20 T-->C, have been identified. 2. To determine the individual site and haplotype effects of these polymorphisms, we generated 16 luciferase-based mutant constructs which were transiently transfected into HEK293 cells, and measured ADRB2 promoter-driven luciferase activity. 3. Two of the 16 mutant constructs, GCCT (-468G, -367C, -47C, -20T) and CTCT, showed a highly significant 3 fold decrease in luciferase induction relative to the reference CTTT. These haplotype effects could not be accounted for by the separate and additive effects of each site. 4. These findings indicate that promoter polymorphisms interact to significantly alter beta(2) adrenergic receptor expression, and should be examined further for their association with disease-related phenotypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466230      PMCID: PMC1573596          DOI: 10.1038/sj.bjp.0704935

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene.

Authors:  M G Scott; C Swan; A P Wheatley; I P Hall
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 2.  Vascular adrenoceptors: an update.

Authors:  S Guimarães; D Moura
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  Site-directed mutagenesis of virtually any plasmid by eliminating a unique site.

Authors:  W P Deng; J A Nickoloff
Journal:  Anal Biochem       Date:  1992-01       Impact factor: 3.365

4.  Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions.

Authors:  B K Kobilka; T Frielle; H G Dohlman; M A Bolanowski; R A Dixon; P Keller; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

5.  Targeted disruption of the beta2 adrenergic receptor gene.

Authors:  A J Chruscinski; D K Rohrer; E Schauble; K H Desai; D Bernstein; B K Kobilka
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

6.  The peptide product of a 5' leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis.

Authors:  A L Parola; B K Kobilka
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

7.  Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings.

Authors:  J Krushkal; R Ferrell; S C Mockrin; S T Turner; C F Sing; E Boerwinkle
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

8.  Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension.

Authors:  M S Bray; J Krushkal; L Li; R Ferrell; S Kardia; C F Sing; S T Turner; E Boerwinkle
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

9.  Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.

Authors:  J Turki; J Pak; S A Green; R J Martin; S B Liggett
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression.

Authors:  D W McGraw; S L Forbes; L A Kramer; S B Liggett
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

View more
  14 in total

1.  Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins.

Authors:  Rohit Loomba; Fangwen Rao; Lian Zhang; Srikrishna Khandrika; Michael G Ziegler; David A Brenner; Daniel T O'Connor
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

2.  Allele-specific binding of airway nuclear extracts to polymorphic beta2-adrenergic receptor 5' sequence.

Authors:  Alfredo Panebra; Mary Rose Schwarb; Clare B Glinka; Stephen B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-25       Impact factor: 6.914

3.  Expression variation of the porcine ADRB2 has a complex genetic background.

Authors:  Eduard Murani; Siriluck Ponsuksili; Henry Reyer; Dörte Wittenburg; Klaus Wimmers
Journal:  Mol Genet Genomics       Date:  2013-08-31       Impact factor: 3.291

4.  Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.

Authors:  Yuqing Chen; Michael S Lipkowitz; Rany M Salem; Maple M Fung; Vibha Bhatnagar; Manjula Mahata; Caroline M Nievergelt; Fangwen Rao; Sushil K Mahata; Nicholas J Schork; Pamela J Hicks; Donald W Bowden; Barry I Freedman; Victoria H Brophy; Daniel T O'Connor
Journal:  Am J Nephrol       Date:  2010-05-19       Impact factor: 3.754

Review 5.  The role of ADRB2 gene polymorphisms in malignancies.

Authors:  Yaqian Wang; Shujuan Jiang
Journal:  Mol Biol Rep       Date:  2021-03-06       Impact factor: 2.316

6.  Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia.

Authors:  N Pottier; S W Paugh; C Ding; D Pei; W Yang; S Das; E H Cook; C-H Pui; M V Relling; M H Cheok; W E Evans
Journal:  Clin Pharmacol Ther       Date:  2010-10-27       Impact factor: 6.875

7.  MGMT DNA repair gene promoter/enhancer haplotypes alter transcription factor binding and gene expression.

Authors:  Meixiang Xu; Courtney E Cross; Jordan T Speidel; Sherif Z Abdel-Rahman
Journal:  Cell Oncol (Dordr)       Date:  2016-06-15       Impact factor: 6.730

8.  Diverse evolutionary histories for beta-adrenoreceptor genes in humans.

Authors:  Rachele Cagliani; Matteo Fumagalli; Uberto Pozzoli; Stefania Riva; Giacomo P Comi; Federica Torri; Fabio Macciardi; Nereo Bresolin; Manuela Sironi
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

9.  Role of ADRB2 gene polymorphism in asthma and response to beta(2)-agonists in Polish children.

Authors:  A Szczepankiewicz; A Breborowicz; P Sobkowiak; L Kramer; A Popiel
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

10.  Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor-mediated responses in human lung mast cells.

Authors:  L J Kay; A Rostami-Hodjegan; S K Suvarna; P T Peachell
Journal:  Br J Pharmacol       Date:  2007-07-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.